What is Beckwith‑Wiedemann syndrome and how is it diagnosed antenatally?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Beckwith-Wiedemann Syndrome: Definition and Antenatal Diagnosis

What is Beckwith-Wiedemann Syndrome?

Beckwith-Wiedemann syndrome (BWS) is a rare congenital overgrowth disorder occurring in approximately 1 in 10,500 births, caused by dysregulation of growth genes on chromosome 11p15.5, and characterized by macrosomia, macroglossia, abdominal wall defects (particularly omphalocele), and a 5-10% risk of embryonal tumors including Wilms tumor and hepatoblastoma 1.

Key Clinical Features

BWS presents with variable manifestations including:

  • Pre- and postnatal overgrowth (macrosomia)
  • Macroglossia (enlarged tongue)
  • Abdominal wall defects (omphalocele or umbilical hernia)
  • Hemihyperplasia (asymmetric overgrowth)
  • Facial nevus flammeus
  • Organomegaly (nephromegaly, hepatomegaly)
  • Embryonal tumor predisposition - Wilms tumor, hepatoblastoma, neuroblastoma, rhabdomyosarcoma 1, 2

Genetic Basis

The syndrome results from imprinting abnormalities at chromosome 11p15.5 affecting genes H19, IGF2, and CDKN1C 1:

  • Loss of methylation at IC2 (most common, ~50% of cases) - 2.6% tumor risk
  • Gain of methylation at IC1 (~20% of cases) - 28% tumor risk
  • Paternal uniparental disomy (pUPD11) (~20% of cases) - 16% tumor risk
  • CDKN1C mutations (~5% of cases) - 6.7% tumor risk
  • Chromosomal rearrangements or duplications (rare) 1

Critical point: At least 85% of cases are not inherited and occur sporadically due to epigenetic changes 1.


Antenatal Diagnosis

Prenatal diagnosis of BWS relies on identifying a combination of ultrasound findings, with the most reliable diagnostic schema requiring either two major criteria OR one major plus two minor criteria 3.

Diagnostic Criteria for Prenatal BWS

Major Criteria:

  • Abdominal wall defect (omphalocele or umbilical hernia)
  • Macroglossia
  • Macrosomia (fetal overgrowth)

Minor Criteria:

  • Nephromegaly or renal dysgenesis
  • Adrenal cytomegaly
  • Polyhydramnios
  • Placentomegaly or placental mesenchymal dysplasia
  • Cardiomegaly
  • Fetal hydrops 3, 4, 2

Imaging Modalities

Ultrasound is the primary screening tool throughout pregnancy:

  • Serial growth assessments to detect macrosomia
  • Detailed anatomic survey for omphalocele (often the first detected finding) 5
  • Evaluation of tongue size and organ dimensions
  • Assessment of amniotic fluid volume 3, 6, 7

MRI can provide additional anatomic detail when ultrasound findings are equivocal, particularly for:

  • Macroglossia confirmation
  • Organomegaly assessment
  • Airway evaluation 7, 2

Molecular Prenatal Testing

When BWS is suspected based on imaging:

  1. Methylation analysis of chromosome 11p15.5 regions (IC1 and IC2) should be performed first on amniotic fluid or chorionic villus sampling 5, 8

  2. If methylation testing is normal but clinical suspicion remains high (especially with isolated omphalocele), proceed to exome sequencing to identify CDKN1C pathogenic variants 5

  3. Timing: Invasive testing is typically performed in the early second trimester to allow for comprehensive methylation analysis 5

Important caveat: Somatic mosaicism can lead to false-negative results in blood or amniotic fluid, so negative molecular testing does not completely exclude BWS if clinical features are present 8.

Emerging Diagnostic Tools

Recent research suggests cell-free DNA (cfDNA) analysis from maternal blood may show promise as a noninvasive biomarker, with BWS-affected fetuses demonstrating elevated fetal fractions (33.9-34.5%) and bimodal fragment size distributions during pregnancy 9. However, this remains investigational and is not yet part of standard clinical practice.


Clinical Implications of Prenatal Diagnosis

Early prenatal diagnosis is critical because it enables:

Immediate Perinatal Planning

  • Delivery at a tertiary center with neonatal intensive care and pediatric surgery capabilities
  • Preparation for neonatal hypoglycemia management (occurs frequently due to hyperinsulinism and requires immediate glucose monitoring to prevent intellectual disability) 6, 2
  • Airway management planning for macroglossia-related obstruction 2
  • Surgical readiness for omphalocele repair 2

Long-term Surveillance Strategy

All children with BWS require tumor surveillance regardless of molecular subtype (though some European centers use genotype-stratified protocols):

  • Wilms tumor screening: Renal ultrasound every 3 months from birth through age 7 years 1, 10
  • Hepatoblastoma screening: Abdominal ultrasound plus serum alpha-fetoprotein (AFP) every 3 months from birth through age 4 years 1, 10

These surveillance recommendations are based on the principle that early tumor detection significantly improves outcomes in conditions with ≥1% tumor risk 1.

Genetic Counseling

  • Most cases (85%) are sporadic with low recurrence risk
  • CDKN1C mutations and chromosomal rearrangements can be familial, requiring evaluation of family members
  • Assisted reproductive technology (ART) pregnancies have increased BWS risk and warrant inclusion in diagnostic considerations 8

Any determination of recurrence risk should be performed by a genetics healthcare professional given the complexity of inheritance patterns 1.


Common Pitfalls

  • Do not dismiss isolated omphalocele as a simple abdominal wall defect—it may be the only early prenatal finding of BWS and warrants detailed family history and consideration of molecular testing 5

  • Negative methylation testing does not exclude BWS due to somatic mosaicism; if clinical suspicion is high, proceed to CDKN1C sequencing or test alternative tissues 5, 8

  • Not all features are present prenatally—macroglossia and macrosomia may not be evident until later in pregnancy or after birth 3, 8

  • Genome-wide paternal uniparental disomy (GWpUPD) can present with BWS features but carries different prognosis and risk for unmasking recessive disorders—consider if phenotype is severe 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.